Headed to ACS San Diego? Join us for Happy Hour!
← Back to glossary

Reactive Oxygen Species (ROS)

Definition
Definition
Definition

Reactive oxygen species (ROS) are chemically reactive molecules that contain oxygen, such as superoxide anion (O₂⁻), hydrogen peroxide (H₂O₂), and hydroxyl radicals (•OH). They are natural byproducts of cellular metabolism but can cause oxidative damage to biomolecules when present in excess, contributing to various diseases and influencing drug efficacy and toxicity.

Importance in Computational Drug Discovery:

  • Guides the design of antioxidants and drugs targeting oxidative stress-related diseases (e.g., cancer, neurodegeneration).
  • Informs the prediction and mitigation of drug-induced oxidative toxicity and side effects.
  • Supports the identification of compounds that modulate ROS production or scavenging pathways.
  • Enables virtual screening and molecular modeling of ROS-generating enzymes or antioxidant targets.
  • Facilitates the study of redox biology and the impact of ROS on drug metabolism and cellular signaling.

Key Tools

  • ChEMBL: Database for bioactivity data on ROS modulators and antioxidant compounds.
  • SwissADME: Predicts redox-related properties and drug-likeness of small molecules.
  • AutoDock Vina: Used for virtual screening of inhibitors or modulators of ROS-generating enzymes.
  • MOE (Molecular Operating Environment): Supports modeling and screening of ROS-related targets and pathways.
  • KNIME Analytics Platform: Enables custom workflows for ROS pathway analysis and compound screening.

Literature

"Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Discovery: Insights from Chemical, Biological, and Computational Models"

  • Publication Date: 2016
  • DOI: 10.1021/acs.jmedchem.6b01243
  • Summary: This comprehensive review discusses the dual role of ROS in physiology and pathology, highlighting their involvement in various diseases and the potential for therapeutic targeting. It also explores computational models for predicting ROS-related drug interactions.

"On the Clinical Pharmacology of Reactive Oxygen Species"

  • Publication Date: 2024
  • DOI: 10.1016/j.pharmrev.2024.100979
  • Summary: This article examines the clinical implications of ROS, emphasizing the need for selective modulation of ROS-producing enzymes like NADPH oxidases. It discusses the challenges and opportunities in developing ROS-targeted therapies for various diseases.

"Reactive Oxygen Species-Responsive Polymer Drug Delivery Systems"

  • Publication Date: 2023
  • DOI: 10.3389/fbioe.2023.1115603
  • Summary: This review focuses on the design and application of ROS-responsive polymers in drug delivery systems. It highlights how these systems can achieve targeted and controlled drug release in response to pathological ROS levels, improving therapeutic efficacy.

"Modulation of Reactive Oxygen Species Homeostasis as a Therapeutic Strategy in Aging"

  • Publication Date: 2022
  • DOI: 10.3389/fragi.2022.905261
  • Summary: This article explores the role of ROS in aging and age-related diseases, discussing how modulation of ROS levels through pharmacological and lifestyle interventions can promote healthy aging and mitigate disease progression.

"Reactive Oxygen Species in Cancer Pathogenesis and Therapy"

  • Publication Date: 2021
  • DOI: 10.1016/j.bulcan.2021.09.026
  • Summary: This review examines the complex role of ROS in cancer development and treatment, detailing how ROS contribute to tumorigenesis and how they can be exploited therapeutically to induce cancer cell death.